Andrew Booth, Chief Financial Officer at AbCellera Biologics Inc. (ABCL), bought 67,500 shares at $14.61 ($993K) on 2021-11-11, disclosed to the SEC on 2021-11-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.61 | 14,000 | $205K | 20.6% |
| 2 | $14.74 | 53,500 | $789K | 79.4% |
| Total | $14.71 avg | 67,500 | $993K | 100% |
| Filing → |
| ABCL | BUY | 2023-05-26 | $99K | — | Filing → |
| ABCL | BUY | 2022-05-16 | $492K | — | Filing → |
| ABCL | SELL | 2021-06-10 | $30.6M | — | Filing → |